Medtronic, Inc. Release: American Academy of Otolaryngology-Head and Neck Surgery Approves Policy Statement on Micropressure Therapy for Ménière’s Disease

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) announced today that the American Academy of Otolaryngology - Head and Neck Surgery approved a policy statement concluding that the use of micropressure for Ménière’s disease including the Medtronic Meniett® device is appropriate when other medical treatments fail.